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Abstract
Background: In functional genomics, transcript measurement is of fundamental importance. Quantitative
reverse transcription polymerase chain reaction (qRT-PCR) assays are the most popular technology and
depend on the initial molecular step, the reverse transcription (RT). This study provides a complex
overview of the influence of elements such as RT systems, amount of background RNA, and transcript
abundance on the efficiency of qRT-PCR. Using qRT-PCR, we compared the efficiency of some commonly
used RT systems and measured the production of PCR-amplifiable products and the influence of PCR
inhibitor contents.
Results: The qRT-PCR assays were conducted using the TaqMan system, although we also tested the
SYBR Green I chemistry, which is not compatible with all the RT systems. When dealing with low-
abundance transcripts, the SuperScript II system generated more detectable molecules than the four other
systems tested: Sensiscript, Omniscript, SuperScript III and PowerScript (P  < 0.05). However, the
Sensiscript and PowerScript systems were more efficient for detecting high-abundance transcripts in the
presence of 1 to 2 µg background RNA (P < 0.05). The most striking aspect was the influence of the
dilution of the RT reaction on the subsequent PCR. Indeed, some inhibition was released when diluted RT
reactions were used for the quantitative PCR measurements. Furthermore, the amount of background
RNA in the RT reaction was also a major component influencing a downstream step in qRT-PCR, the PCR
reaction. Whereas Sensiscript was less biased, the other systems contained an important source of PCR
inhibitors, interfering as much as 70% with the qRT-PCR.
Conclusion: This study provides a complex overview of the influence of elements such as RT systems,
qRTPCR chemistry, amount of background RNA, and transcript abundance on the efficiency of qRT-PCR.
Whereas the most significant influencing factor is the presence of inhibitors in the RT systems, total
background RNA is also a major influencing component that affects the PCR reaction. Whenever the aim
of a study is to obtain a precise gene expression measurement or to profile the global transcriptome (e.g.
microarray), the RT step is critical and should be examined with care.
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Background
In functional genomics, transcript measurement is of fun-
damental importance, since it not only reveals the activity
of a genome but also delivers information on the regula-
tion of biochemical pathways. In that connection, many
efforts are directed toward improving detection technolo-
gies that hold promise for the discovery of new genes or
linking gene activity to new biochemical pathways
involved in the development and regulation of mamma-
lian cells. Among the most popular technologies, the
microarray tool is used for large-scale gene expression pro-
filing, while the quantitative reverse transcription
polymerase chain reaction (qRT-PCR) assay is applied
when a precise gene-by-gene interrogation is required.
One of the limitations of current technologies, such as
microarray, is that a relatively large amount of cDNA is
required to generate labelled cDNA [1]. Irrespective of our
ability to amplify RNA from tissue, all methods depend
on the efficiency of the initial molecular step, the reverse
transcription (RT). This is of prime importance when the
substrate is limited (nanograms of RNA), such as in biop-
sies, lasercapture microdissection, historical samples, or
specialised cells that are very poor in RNA, such as sper-
matozoa. Whether the problem is filling the need for
micrograms of cDNA in probing microarrays, or depicting
an accurate gene expression profile using the qRT-PCR
approach, an efficient, sensitive and reliable RNA-to-
cDNA conversion step is required. Indeed, reverse tran-
scriptase (RTase) needs to be efficient over a wide
dynamic range in order to efficiently convert both high-
abundance and rare transcripts into cDNA, despite the
total amount of "background" RNA in the tube assay. This
is one of the most crucial steps in a quantitative study such
as qRT-PCR, and it is no less important for whole tran-
scriptome interrogation in microarray studies.
Quantitative RT-PCR is by all means the most accurate
approach to building a gene expression profile. Whereas
much attention is dedicated to real-time technology for
studying the quantitative aspect of transcript abundance,
the importance of the RTase contribution is generally a
trivial feature. One author has long been raising concerns
about the influence of the RT step in qRT-PCR [2,3]. How-
ever, no studies have reported a quantitative appreciation
of either the influence of the amount of background RNA
in the RT assay or the influence of RT conditions on the
RNA-to-cDNA conversion capacity of low copy number
transcripts. This is of prime importance, since transcripts
of gene regulators or modulators, such as transcription
factors, silencers and enhancers, are often present in low
abundance. Indeed, these rare transcripts are sometimes
not detected by microarray [4] but rather when a normal-
isation step such as suppressive subtractive hybridisation
is performed, allowing a 10-fold enrichment in lowabun-
dance transcripts [5]. Evaluating the capacity and detec-
tion limits of different commercial RT systems in regard to
these conditions is fundamental to maximising the sensi-
tivity of the qRT-PCR. For that reason, the first stage of
gene expression analysis, the RT step, was examined in
order to give further directives about the appropriate
choice of RT system for a qRT-PCR assay.
In this study, we addressed the efficiency of different com-
mercial RTases and assessed their sensitivity in their
respective systems, i.e. following the vendors' recommen-
dations. We found that, whereas the RNA-to-cDNA con-
version of abundant transcripts is efficient with all
commercial RT systems tested in the presence of various
amounts of background RNA, cDNA cannot be detected
with certain RT systems when low-abundance transcripts
are involved. We found that the RT step is critical for gene
analysis and that a judicious choice is required when start-
ing RNA material is limited.
Results
Reproducibility of the standard curves
The use of serial dilutions of cDNA (RT reactions) to con-
struct the calibration curves generates PCR amplification
efficiency superior to 100% when first points are con-
served in the slope [6]. This distortion effect is caused by
the influence of some PCR inhibitors present in cDNA, a
problem that is attenuated in the subsequent diluted sam-
ples and for which normalisation procedures have been
suggested [7]. To circumvent these wrongfully derived
PCR amplification efficiencies and instead use absolute
DNA quantification, DNA fragments (purified amplicons
of the target gene) were used as reference in this study. The
reference cDNA fragments of the GNPDA and EGFP genes
were cloned into a T/A cloning vector, and their identity
was confirmed by sequencing. Purified and quantified
PCR products of the GNPDA and EGFP genes were serially
diluted down to the attogram (ag: 10-18 gram) and femto-
gram (fg: 10-15 gram) range, respectively, and were used as
standard templates. Quantitative real-time PCR efficien-
cies were calculated from the given slopes (in triplicate per
plate) and showed high efficiency rates per cycle (1.922
<E  > 1.976) in the DNA calibration curve model [see
Additional file 1]. Cycle threshold (Ct) values for each
dilution point of the triplicate standard curves within each
plate presented a coefficient of variation (CV) below 1%,
indicating a very low technical variability (data not
shown). Gathering of the qRT-PCR results for the standard
curves obtained from several assays (plates) revealed that
the molecular assay was highly reproducible, as judged by
the low variation around each of the six dilution points:
CVs varied between 1.61% and 3.18% for the respective
nine plates totalling 27 EGFP  calibration curves (table
S2a, [see Additional file 1]). A clearly linear relationship
existed between the dilution points (log of number of
copies) and the average Ct values for both the GNPDA (R2BMC Molecular Biology 2007, 8:93 http://www.biomedcentral.com/1471-2199/8/93
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= 0.9940 ± 0.0068) and the EGFP (R2 = 0.9929 ± 0.005)
reference genes as measured across assays [see Additional
file 1]. The detection assay is therefore reliable and sensi-
tive given the high linearity throughout the study.
Whereas the TaqMan assay is highly specific due to the
prerequisite of both primers and probe annealing for sig-
nal detection, the SYBR Green I system relies on the incor-
poration of a fluorescent dye into double-stranded DNA.
Therefore, in order to confirm the specificity of the meas-
ured amplicons, melting curve analysis was systematically
performed for all samples analysed with the SYBR Green I
system. Products from the standard curves showed no
primer-dimers, although there was a single sharp peak
with the expected melting point in the dissociation curve
analysis, as well as a fragment of expected length (78 bp)
in acrylamide gel electrophoresis corresponding to the
GNPDA  gene as confirmed by sequencing (data not
shown).
Determination of the amount of the target transcript for 
conditions of qRT-PCR measurements of abundant and 
weakly expressed genes
To address the efficiency of commercial RT systems, we set
up a qRT-PCR system that could independently monitor
the influence of the amount of background RNA on the
respective RT systems and their efficiency based on the
transcript abundance. The proposed model used different
amounts of background RNA, with a fixed amount of the
target gene to be converted into cDNA by different com-
mercial RT systems and measured by qPCR. The commer-
cial RT systems tested were Sensiscript, Omniscript,
SuperScript II, SuperScript III, and PowerScript. In order
to measure this difference on a large spectrum of back-
ground RNA, given that DNA and RNA concentrations are
important influencing factors [8-10], the study used total
RNA extracted from the same testis tissue (Methods). No
bias could therefore be attributed to sample preparation
or animal individuality. Furthermore, testes are not a sig-
nificant source of muscle, fat or blood, all tissues known
to generate traces of PCR inhibitors that would interfere
with qRT-PCR [11]. In addition, we chose to spike the RT
assays with an exogenous transcript, the EGFP gene, in
order to control the amount of target transcripts. The first
assay was performed in order to determine the adequate
amounts of EGFP mRNA to mimic abundant and weakly
expressed gene conditions in the RT reactions. The in vitro
transcribed EGFP mRNA (Methods) was used to identify
the detection limits of each of the commercial RT systems
under study. For each RT reaction, 2 µg background RNA
was used based on the commercial dynamic range state-
ments for all enzymes, with the exception of the Sensis-
cript RTase (dynamic range <50 ng), for which the RT
assays were conducted with 50 ng background RNA
(Table 1). One RT assay was performed for each EGFP
quantity with the different RT systems. These RT reactions
contained either 0 fg (0 copies), 1 fg (2,565 copies), 10 fg
(25,650copies), 25 fg (64,138 copies), 1 pg (2.57 × 106
copies), 5 pg (1.28 × 107 copies), or 10 pg (2.57 × 107 cop-
ies) EGFP mRNA. Preliminary results showed a clear line-
arity in the range of 10 fg to 10 pg between the amount of
input  EGFP  mRNA and the number of cDNA copies
detected in the PCR reactions (data not shown). However,
when the amount of mRNA was set at 1 fg (approximately
2,500 molecules) or less, there were great differences
among the RT systems (data not shown). Indeed, in the
presence of 1 fg EGFP transcripts, only trace amounts of
amplifiable cDNA were detected by qRT-PCR with the
Omniscript RT system, whereas substantial copies of
EGFP cDNA were obtained with the other RTases. There-
fore, 2,500 copies (1 fg) was chosen as the relatively small
target RNA amount to spike in order to create the low tran-
script abundance condition. This number of mRNA copies
corresponds to 250 molecules of cDNA to be quantified,
since 1/10 of the RT reaction (2 µl out of 20) is used for
the qPCR. Even if there was still an increase in the detected
amount of EGFP cDNA molecules with 5 or 10 pg EGFP
mRNA in comparison with 1 pg, the amount of 1 pg EGFP
mRNA (2.57 × 106 copies) was chosen to represent the
high transcript level condition, since we did not want to
measure the RT efficiencies in a saturated or a biologically
non-relevant system. Indeed, more than a 1,000 fold
increase in transcript level (1 pg versus 1 fg EGFP mRNA)
may not be biologically appropriate.
Comparison of the efficiency of five commercial RT 
systems measured by qRT-PCR in abundant or weakly 
expressed gene conditions
We attempted to evaluate the capacity of different com-
mercial RTases to convert RNA into cDNA in conditions
that mimic the detection of an abundant or weakly
expressed gene. Notwithstanding the influence of some
Table 1: Dynamic range of template RNA amount for the five 
commercial RT systems tested.
Commercial name Type of RTa Dynamic range (ng)
Omniscript ? 50–2,000
PowerScript MMLV 1,000–5,000
Sensiscript ? < 50
SuperScript II MMLV 1–5,000
SuperScript III MMLV 0.01–5,000
aBoth the Omniscript and the Sensiscript RTases retain RNase H 
activity. They are different from the RTases of Moloney murine 
leukaemia virus (MMLV) or avian myeloblastosis virus (AMV) origin 
(Sensiscript and Omniscript reverse transcriptase handbook, Qiagen). 
The Sensiscript RTase is a recombinant heterodimeric enzyme 
expressed in E. coli. TheSuperScript II and SuperScript III RTases are 
an engineered version of MMLV RTase with reduced RNase H activity 
and increased thermal stability. The PowerScript RTase is a point 
mutant of MMLV RTase, which lacks the RNase H enzyme and retains 
wild-type polymerase activity, thus being able to synthesise longer 
cDNA fragments [35].BMC Molecular Biology 2007, 8:93 http://www.biomedcentral.com/1471-2199/8/93
Page 4 of 18
(page number not for citation purposes)
RT components on the subsequent PCR, we chose first to
measure the cDNA copies of the EGFP gene in the undi-
luted RT reaction. Indeed, most of the qRT-PCR studies
are carried out using a fraction of the non-purified RT
samples, whereas other quantitative assays are performed
as "one-tube qRT-PCR" reactions. The comparative study
was also performed over a broad range of background
RNA in order to measure the influence of background
RNA on the RT-PCR yield. Figure 1 presents the number of
detectable cDNA copies of the EGFP gene measured by
qRT-PCR with the five commercial RT systems. It is worthy
of note that the performance of the RT systems was influ-
enced by the presence of the background RNA. This influ-
ence was apparent for both "low-abundance" (Figure 1A)
and "high-abundance" (Figure 1B) conditions. Further-
more, the performance of the RT-PCR systems depended
on the gene abundance. When the target gene was present
in a low copy number (Figure 1A), more cDNA copies
were detected using SuperScript II than the other systems
(P < 0.05). The Omniscript system was inefficient both for
low-abundance transcript conditions (Figure 1A) and, in
abundant transcript conditions, when = 100 ng back-
ground RNA was used (Figure 1B). In abundant transcript
conditions, the different RT systems were more compara-
ble but still presented differences. In the presence of 1 to
2 µg background RNA, both the Sensiscript and the Pow-
erScript systems were superior to Omniscript, SuperScript
II and SuperScript III (P < 0.05; Table S3). Concerning the
influence of the background RNA on the RTase efficiency,
the difference measured in the EGFP transcript was only
significant when comparing RT assays containing
amounts of background RNA that differed by more than
twofold. For example, results obtained with 50 ng were
not different from the 100 ng conditions but statistically
different from 1 µg (data not shown). In other words, the
impact of the variation of the amount of total RNA on the
qRT-PCR is significant only when this variation is pro-
nounced. The Sensiscript system showed a statistically
superior yield in the presence of 50 ng background RNA
(P < 0.05; Figure 1B), according to the specification of the
enzyme (Table 1). However, this advantage was only
noticeable when the measured transcripts were abundant.
The Sensiscript system seemed to be more reliable in the
presence of 10 to 100 ng total RNA, as indicated by the
weaker standard deviation (SD).
Results reported in Figure 1 are also presented in Table 2
and 3 in terms of copy number and RT-PCR efficiency
(detection yield: DY). Ct values are also reported. Since
the amount of mRNA molecules used to spike is known,
and since the calibration curve is established using
defined amounts of molecules, it is possible to calculate
the real efficiency of the RT system. The DY of a particular
reaction is calculated using the following equation:
To assess the DY at a specific dilution point, 1/10 of the
spiked amount is used in the calculation, since 2 µl of the
20-µl RT reaction was used in the PCR assay. Conse-
quently, the initial numbers of molecules used for the cal-
culation of the high (1 pg = 2.56 × 106 molecules) and low
(1 fg = 2.56 × 103 molecules) transcript amounts were,
respectively, 2.56 × 105 and 2.56 × 102 copies. Calculation
of the DY demonstrated once again the inefficiency of the
Omniscript system in low-abundance transcript and low
background RNA conditions (Table 2). When the detec-
tion system was set to measure a low-abundance gene in a
2-µg background RNA assay, SuperScriptII was the only
system that seemed to recover almost 100% of the seeded
transcripts, whereas the Sensiscript, SuperScript III, and
PowerScript systems detected only 10.63%, 12.37%, and
8.23% of the transcripts, respectively. In contrast, Power-
Script and Sensiscript were the best-performing systems in
the presence of high-abundance transcripts as judged by
the DY, which exceeded 50% in 2-µg background RNA
assays. The RT systems could therefore be saturated or
influenced by inhibitory factors, a dimension that we
examine in the next section.
We also verified the efficiency of the RT systems in con-
verting into cDNA a testis transcript, i.e.a transcript
present in the background RNA. We quantified the
number of copies of GNPDA cDNAs in the same RT sam-
ples that we used for detecting the 1 pg EGFP transcripts
(Figure 1B). This time, the RT samples were quantified
using the SYBR Green I chemistry (GNPDA gene) and the
appropriate qRTPCR primers [see Additional file 2]. The
results are reported in Table 2 and 3, and the statistical
analysis for the EGFP and GNPDA quantifications are pre-
sented in supplementary tables [see Additional files 3 and
4]. The initial evidence showed that no quantification was
obtained with the Omniscript system, although the EGFP
gene was detectable with the TaqMan technology using
the same RT samples. The Sensiscript system was the most
sensitive detection assay for the GNPDA gene in the pres-
ence of 1 to 2 µg background RNA, a result that was 50%
superior to that of SuperScript II (the next efficient sys-
tem), even if the Sensiscript dynamic range is < 50 ng
(Table 1).
Influence of the RT components on qPCR and inhibition 
release by dilution
In the next two experiments, we attempted to evaluate the
influence of RT contents and the amount of background
RNA on the qRT-PCR assays using the serial dilution
method, which is the fastest and most direct way to detect
the presence of inhibitors in PCR reactions. The same
DY
cDNA copies detected by qRT-PCR
Number of   copies sp
=
EGFP i iked in the RT sample
×100BMC Molecular Biology 2007, 8:93 http://www.biomedcentral.com/1471-2199/8/93
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Quantitative measurements of RT reactions performed with five commercial systems Figure 1
Quantitative measurements of RT reactions performed with five commercial systems. Amounts equal to 1/10 (2 
µl) of the undiluted RT samples were quantified by qPCR (two-step qRT-PCR). Data are reported as the number of amplifiable 
cDNA copies in RT reactions spiked with 1 fg (A) or 1 pg (B) EGFP-template mRNA. All RT systems were tested and all results 
are reported, except for the Omniscript system in the presence of low-abundance transcript (A), which was undetectable. All 
RT reactions were performed and quantified in triplicate for each amount of background RNA ranging from 10 ng to 2 µg. 
Absolute values of EGFP copy number are deduced from a standard curve (Supplementary Table S1a) established with a puri-
fied EGFP DNA fragment (Methods). Statistical analysis is presented in Supplementary Table S3. *Different from other RT sys-
tems within a different background RNA quantity (P < 0.05; Supplementary Table S3).
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Table 2: Detection yield, copy number and cycle threshold obtained in qPCR for the RT systems Sensiscript, Omniscript, and SuperScript II.
Background RNA (ng) 0 10 25 50 100 1000 2000
RT systemsa Datab
Sensiscript
DY (%) 0.62 1.36 7.69 14.57 16.64 13.61 10.63
Low copy copy num. ± SD 2 ± 2 3 ± 4 20 ± 18 37 ± 11 43 ± 21 35 ± 19 27 ± 24
(Ct ± SD) (39.52 ± 0.68) (39.28 ± 0.71) (37.19 ± 2.45) (35.35 ± 0.43) (35.34 ± 0.72) (35.61 ± 0.93) (36.87 ± 2.71)
High copy DY (%) 3.92 25.61 29.79 39.26 38.77 48.33 50.41
copy num. ± SD 10 068 ± 8880 65 700 ± 9128 76 433 ± 833 100 733 ± 18 034 99 467 ± 9 089 124 000 ± 21 071 129 333 ± 34 020
(Ct ± SD) (30.6 ± 7.14) (24.24 ± 0.21) (24.02 ± 0.02) (23.62 ± 0.28) (23.64 ± 0.14) (23.29 ± 0.29) (23.67 ± 0.14)
GNPDA copy num. ± SD 0 ± 0 73 ± 25 236 ± 37 691 ± 39 2 150 ± 806 26 395 ± 1 404 42 488 ± 6 724
(Ct ± SD) (40 ± 0) (32 ± 0.62) (30.03 ± 0.3) (28.21 ± 0.09) (26.42 ± 0.58) (22.22 ± 0.09) (21.45 ± 0.26)
Omniscript
Low copy DY & copy num. N/A N/A N/A N/A N/A N/A N/A
DY (%) 0.00 0.00 0.00 0.24 2.16 38.46 38.56
High copy copy num. ± SD 0 ± 0 0 ± 0 9 ± 15 623 ± 368 5 548 ± 4 152 98 664 ± 5 062 98 927 ± 11 165
(Ct ± SD) (40 ± 0) (40 ± 0) (38.41 ± 2.75) (30.73 ± 1.59) (27.53 ± 2.1) (22.44 ± 0.08) (22.44 ± 0.17)
GNPDA copy num. ± %
(Ct ± SD)
primer dimer primer dimer primer dimer primer dimer primer dimer primer dimer primer dimer
SuperScript II
DY (%) 19.80 49.43 70.14 66.30 81.33 102.44 97.38
Low copy copy num. ± SD 51 ± 44 127 ± 39 180 ± 18 170 ± 49 209 ± 12 263 ± 40 250 ± 106
(Ct ± SD) (34.05 ± 0.04) (33.41 ± 0.51) (32.72 ± 0.19) (32.82 ± 0.42) (32.47 ± 0.09) (32.15 ± 0.21) (32.32 ± 0.7)
DY (%) 13.30 22.33 16.69 18.86 27.31 31.33 36.81
High copy copy num. ± SD 34 127 ± 4 284 57 277 ± 5 106 42 814 ± 26,175 48 389 ± 24 717 70 062 ± 8 760 80 366 ± 19 132 94 447 ± 10 237
(Ct ± SD) (23.52 ± 0.19) (22.75 ± 0.14) (23.48 ± 1.19) (23.18 ± 0.98) (22.45 ± 0.19) (22.28 ± 0.4) (22 ± 0.16)
GNPDA copy num. ± SD 5 ± 9 102 ± 48 351 ± 201 1 122 ± 608 2 401 ± 752 19 088 ± 3 540 22 758 ± 1 815
(Ct ± SD) (38.79 ± 2.1) (30.84 ± 1.17) (28.6 ± 1.12) (26.43 ± 0.91) (24.95 ± 0.57) (21.2 ± 0.35) (20.86 ± 0.14)
aRT systems tested were Sensiscript. Omniscript. SuperScript II. SuperScript III. and PowerScript; low copy. RT samples spiked with 2.6 × 103 EGFP mRNA copies; high copy. RT samples 
spiked with 2.6 × 106 EGFP mRNA copies.
bDY (detection yield) was calculated using the equation described in Results and the copy number (num.) was derived from the calibration curve for a given cycle threshold value (CT) 
[see Additional file 2];SD. standard deviation.B
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Table 3: Detection yield, copy number and cycle threshold obtained in qPCR for the commercial RT systems SuperScript III and PowerScript
Background RNA (ng) 0 10 25 50 100 1000 2000
RT systemsa Datab
SuperScript III
DY (%) 3.75 6.30 2.90 2.49 4.07 20.37 12.37
Low copy copy num. ± SD 10 ± 5 16 ± 20 7 ± 3 6 ± 5 10 ± 1 52 ± 28 32 ± 6
(Ct ± SD) (36.61 ± 1.44) (37.87 ± 1.13) (36.65 ± 0.6) (37.19 ± 1.21) (36.06 ± 0.2) (33.89 ± 0.98) (34.41 ± 0.2)
DY (%) 4.48 6.81 7.82 13.78 20.11 36.31 34.48
High copy copy num. ± SD 11 503 ± 6 190 17479 ± 1 861 20 053 ± 1 168 35 342 ± 4 588 51 592 ± 2 574 93 150 ± 10 206 88 458 ± 6 161
(Ct ± SD) (26.28 ± 0.99) (25.51 ± 0.11) (25.21 ± 0.09) (24.37 ± 0.2) (23.8 ± 0.07) (22.93 ± 0.16) (23 ± 0.01)
GNPDA copy num. ± SD 0 ± 0 26 ± 3 99 ± 12 142 ± 24 229 ± 31 1 653 ± N/A 5 314 ± 1 090
(Ct ± SD) (40 ± 0) (33.27 ± 0.29) (30.98 ± 0.16) (30.35 ± 0.29) (29.55 ± 0.22) (26.22 ± N/A) (24.29 ± 0.37)
PowerScript
DY (%) 1.21 3.97 5.12 3.61 3.61 17.67 8.23
Low copy copy num. ± SD 3 ± 1 10 ± 5 13 ± 3 9 ± 3 11 ± 5 45 ± 18 21 ± 5
(Ct ± SD) (38.34 ± 0.47) (36.48 ± 0.9) (35.99 ± 0.41) (36.56 ± 0.58) (36.35 ± 0.76) (34.17 ± 0.75) (35.27 ± 0.37)
DY (%) 9.29 12.89 23.99 18.69 27.28 54.55 59.43
High copy copy num. ± SD 23 837 ± 723 33 078 ± 4 291 61 560 ± 340320 47 944 ± 9 523 69 982 ± 20 743 139 950 ± 10 479 152 480 ± 9 523
(Ct ± SD) (6.01 ± 0.05) (25.53 ± 0.2) (24.72 ± 0.77) (23.2 ± 0.09) (24.42 ± 0.45) (23.33 ± 0.12) (23.2 ± 0.09)
GNPDA copy num. ± SD 2 ± 1 31 ± 3 168 ± 16 35 ± 8 58 ± 40 2 440 ± 650 6 118 ± 308
(Ct ± SD) (36.85 ± 1.26) (32.47 ± 0.18) (30 ± 0.11) (32.29 ± 0.35) (31.9 ± 1.39) (26.07 ± 0.38) (24.69 ± 0.07)
aRT systems tested were Sensiscript. Omniscript. SuperScript II. SuperScript III. and PowerScript; low copy. RT samples spiked with 2.6 × 103 EGFP mRNA copies; high copy. RT samples spiked 
with 2.6 × 106 EGFP mRNA copies.
bDY (detection yield) was calculated using the equation described in Results and the copy number (num.) was derived from the calibration curve for a given cycle threshold value (CT) [see 
Additional file 2];SD. standard deviation.BMC Molecular Biology 2007, 8:93 http://www.biomedcentral.com/1471-2199/8/93
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experimental design was used, i.e. defined conditions of
background RNA in the presence of known amounts of
target transcript. However, RT reactions were only spiked
with 0.1 pg EGFP  mRNA, since a 1:50 dilution of RT
spiked with lower amounts resulted in a loss of signal
(data not shown). All RT reactions (one RT per condition)
were performed with the same amount of EGFP  tran-
scripts in the presence of different amounts of background
RNA, for the fivecommercial RT systems. Quantitative
measurements (in triplicate) of each RT reaction were per-
formed in parallel on undiluted and 1:50 diluted samples
(Figure 2). The same quantities of RTase and EGFP tran-
scripts were used in the RT reactions. For a given RT sys-
tem, therefore, when comparing the diluted RT samples
together or the undiluted RT samples together, the differ-
ences observed can be due only to the influence of the
background RNA. In general, more cDNA molecules were
detected in the diluted RT samples than in the corre-
sponding undiluted ones. For RT reactions containing 2
µg background RNA, the greatest difference between the
diluted and undiluted samples was observed with Super-
Script II. In general, the effect of the dilution was weak for
the RT performed in the presence of 1 to 2 µg total RNA,
whereas this discrepancy increased in the presence of low
background RNA, reaching a total absence of detection
with undiluted samples at 0 ng background RNA for both
the SuperScript II and Omniscript systems. Curiously,
when the Omniscript RT assays were diluted, the number
of gene copies measured by qRT-PCR for RT containing <
100 ng background RNA was superior to the results for the
SuperScript II and III systems and comparable to those for
the Sensiscript and PowerScript systems. Indeed, whereas
few molecules were detected in undiluted samples in the
presence of < 100 ng background RNA, this inhibition was
Effect of RT reaction dilution on the measurements of PCR amplifiable EGFP cDNA Figure 2
Effect of RT reaction dilution on the measurements of PCR amplifiable EGFP cDNA. Quantitative PCR was per-
formed in triplicate on undiluted and diluted (1:50) RT samples prepared with each of the five commercial RT systems. The 
same quantity of EGFP mRNA (0.1 pg) was used to spike RT reactions in the presence of different amounts (0 to 2,000 ng) of 
background RNA.
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partially released for diluted samples. In other words,
even if some RT systems are better than others, using
diluted RT samples improved the PCR sensitivity, an effect
that was more pronounced in the presence of low back-
ground RNA. Indeed, there was a synergetic effect between
the amount of background RNA and RT-PCR sensitivity as
observed when undiluted samples were quantified, a phe-
nomenon that was attenuated with the dilution. It is not
clear how the low background RNA influenced the PCR
efficiency in undiluted samples, or how the background
RNA could increase the PCR efficiency when diluted along
with the RT sample. This aspect is further discussed below
with the perspective enunciated by Suslov and Steindler
[6], who hypothesised the role of the RTase in the PCR
step.
When the diluted samples were quantified, it appeared
that almost the same amount of molecules was detected
in low versus high background RNA, for at least three of
the RT systems. Indeed, the PowerScript, Sensiscript, and
SuperScript III systems presented a similar efficiency in
the range of 25 to 2,000 ng background RNA. That finding
suggested that the difference observed between low and
high background RNA, when comparing undiluted RT
samples, could not be attributed to weak RTase perform-
ance in the presence of low background RNA. Indeed, the
poor qRT-PCR detection in the presence of low back-
ground RNA was not apparent when the samples were
diluted before the qPCR step, indicating that the RT reac-
tion was still efficient in the presence of low background
RNA and that the reason for low detection with undiluted
samples came after the RTase step. Therefore, it suggests
not only that some RT contents influenced subsequent
PCR but that the extent of this influence depended on the
RT system.
Quantitative PCR measurement of inhibition by RT 
components
At the time of writing the present manuscript, an interest-
ing paper reporting quantitative data about the effect of
some components of the SuperScript III reaction was pub-
lished. The authors of that paper reported that the Super-
Script III system contains PCR inhibitors and could lead to
an overestimation of amplification efficiency under cer-
tain conditions [6]. In order to evaluate the importance of
this phenomenon with the different commercial RT sys-
tems, we followed the same procedure that had already
been carried out. We tested the different RT systems in
triplicate spiked with 1 pg EGFP mRNA, and ran all the RT
reactions in triplicate using undiluted and serially diluted
(2-, 8-, 16-, 32-, 64-, and 128-fold) samples. The dilution
solution contained 50 ng/µl yeast tRNA, and all samples
were set to contain a final amount of 2µg background
RNA [6]. Again, the number of copies detected was fairly
similar within the triplicates, as judged by the low SD
(data not shown). The onset of fluorescence (Ct) varied
when either the undiluted or the diluted cDNAs were
used. However, this gap was variable depending on the RT
system used (data not shown). The respective PCR effi-
ciencies were calculated using the equation E = 10(-1/slope)
and are presented in Table 4 as percentages. These efficien-
cies were calculated for a slope determined (i) with all
points, (ii) without the first point (undiluted RT sample),
or (iii) without the first two points (undiluted and two-
fold diluted samples) [6]. An efficiency of 100% corre-
sponds to a slope value of -3.32. From these results, we
deduced the inhibition percentage (IP), which is calcu-
lated using the following equation:
where ∆ cDNA copies is the difference between the number
of copies detected in the undiluted RT and the number of
copies corresponding to the 128-fold diluted RT sample
corrected for the dilution (× 128). The Sensiscript RT sys-
tem contained the least inhibitory components with only
14.73 ± 6.09% PCR inhibition, followed by the Omnis-
cript RT system (31.23 ± 23.50%). These RT systems are
quite reliable, since the estimated amplification efficiency
calculated with or without the first two points was close to
100%, which is representative of an unbiased PCR reac-
tion. These results are also in accordance with those
reported in Figure 2 for 2 µg background RNA. The worst
deviations were observed with the SuperScript III RT sys-
tem, with an average IP score of 79.31 ± 2.85%. Quite log-
ically, the RT systems providing the highest IPs were also
those for which the distortions in amplification efficien-
cies were the greatest, especially when the first two points
were included. This suggested that the higher the starting
IP at the first point, the lower the possibility of detecting
the correct amplification efficiency. In other words, the
most concentrated points are under the biggest inhibitory
influence; these points should always be excluded from a
calibration curve. In consequence, the same reasoning
must be applied to the RT samples; they should not be
quantified as undiluted samples but rather in conditions
(i.e.at least a 1:10 dilution or following the purification
step) that ensure that the subsequent qRTPCR will not be
affected by the PCR inhibition effect.
Discussion
Dynamic range and detection efficiency of the RT systems
Notwithstanding the ability to detect a broad range of
gene copies, the most challenging aspect of a qRT-PCR
study is the extraction of the absolute or most representa-
tive transcript quantity of an RT sample. It is usually
accepted that the RNA quantity of an RT assay determines
the choice of RTase based on the manufacturer's specifica-
tions. However, it is not clear whether the suggested
IP
 cDNA copies of the   reference gene
Number of copie
=
∆ EGFP
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dynamic ranges take into account the abundance of tar-
geted transcripts. Furthermore, the manufacturer's specifi-
cations do not indicate if the RT system is directly
transposable to qPCR assays. Depending on the RT system
used, we had previously observed inconsistencies between
end-point PCR and qPCR measurements (data not
shown). We therefore hypothesised that each RT system
would have its respective enzyme efficiency and PCR
adaptability. Because qPCR assay is more precise–qRT-
PCR displays a dynamic range that is three to four times
greater than end-point PCR [12]–the qPCR technology is
the more suitable approach for such a comparison [13].
Indeed, we were able to detect a five-log range of gene cop-
ies [see Additional file 1] using both the TaqMan and
SYBR Green I systems.
We established an informative qRT-PCR assay that
allowed quantification of an exogenous transcript (EGFP)
introduced into the RT reactions within defined condi-
tions, with the purpose of testing the influence of the fol-
lowing parameters on PCR reactions: the RT system, the
abundance of the quantified mRNA (transcript level), the
amount of background RNA, and the dilution. Therefore,
the same template was quantified in different conditions,
and the differences observed could not be attributed to
the nature of the transcript. Then, the RTase was primed
Table 4: Inhibition effect of the RT contents of five commercial RT systems measured by qRT-PCR.
RT systems Slopea SD Efficiencya, b R2 SD Average IPa
Sensiscript
E/R2 - all points 14.7 ± 6.1%
-3.393 ± 0.030 97.13 ± 5.00% 0.9981 ± 0.0016
E/R2 - w/o 1st point
-3.464 ± 0.041 94.42 ± 1.53% 0.9983 ± 0.0017
E/R2 - w/o 1st 2 points
-3.519 ± 0.089 92.45 ± 3.12% 0.9968 ± 0.0029
Omniscript
E/R2 - all points 31.2 ± 23.5%
-3.227 ± 0.054 104.14 ± 2.42% 0.9958 ± 0.0035
E/R2 - w/o 1st point
-3.323 ± 0.057 99.98 ± 2.37% 0.9957 ± 0.0038
E/R2 - w/o 1st 2 points
-3.473 ± 0.208 94.50 ± 8.10% 0.9969 ± 0.0019
SuperScript II
E/R2 - all points 59.7 ± 6.8%
-2.862 ± 0.109 123.79 ± 6.95% 0.9907 ± 0.0029
E/R2 - w/o 1st point
-3.004 ± 0.122 115.50 ± 6.93% 0.9920 ± 0.0013
E/R2 - w/o 1–2 points
-3.303 ± 0.121 100.99 ± 5.26% 0.9971 ± 0.0034
SuperScript III
E/R2 - all points 79.3 ± 2.9%
-2.400 ± 0.095 161.44 ± 10.16% 0.9830 ± 0.0057
E/R2 - w/o 1st point
-2.583 ± 0.083 144.07 ± 6.84% 0.9898 ± 0.0040
E/R2 - w/o 1–2 points
-2.882 ± 0.069 122.43 ± 4.34% 0.9980 ± 0.0024
PowerScript
E/R2- all points 69.3 ± 2.1%
-2.568 ± 0.063 145.27 ± 5.49% 0.9693 ± 0.0113
E/R2 - w/o 1st point
-2.759 ± 0.168 131.12 ± 12.38% 0.9694 ± 0.0038
E/R2 - w/o 1–2 points
-3.203 ± 0.141 105.50 ± 6.71% 0.9817 ± 0.0167
aResults report the means of triplicate assays for each RT system.
bAmplification efficiency is calculated using the equation E% = (1 - 10(-1/slope)) × 100, where 100% PCR efficiency corresponds to a slope (∆ Ct) of -
3.3; E and coefficient of correlation (R2) are derived from the slope of a sample's calibration curve; SD, standard deviation.BMC Molecular Biology 2007, 8:93 http://www.biomedcentral.com/1471-2199/8/93
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with an oligo(dT)12–18. Hence, the present paper reports a
representative evaluation of the PCRdetectable amount of
mRNA-to-cDNA copies. In theory, the "random" approach
primes the RT at multiple origins along every RNA tem-
plate, hence producing more than one cDNA molecule
per original mRNA target. Nonetheless, we did not
observe a better yield in EGFP detection with the random
priming kit (i.e. the High-Capacity cDNA Archive Kit from
Applied Biosystems) when compared to the SuperScript II
system, using either diluted or undiluted RT reactions,
and the TaqMan or SYBR Green detection system (data
not shown). It is well accepted that qPCR is robust and
predictable in defined conditions. Indeed, when the
quantity of background RNA was constant, and for most
of the tested range of mRNA quantity introduced in the RT
reactions, we observed a linear relationship between the
gene copies detected by qRTPCR and the starting
amounts. The amounts of EGFP mRNA ranging from 2.2
× 104 to 2.6 × 107 copies delivered proportional PCR-
detectable cDNA molecules (data not shown). This repre-
sentation is generally supported in the technical bulletin
provided by each company. However, a discrepancy
between RT systems was observed at a very low transcript
level (1 fg, equivalent to 2,600 molecules of EGFP mRNA
in the RT assay). We then designed the experiment to sta-
tistically explore this difference further by repeating the RT
assays using this low amount of transcripts (2.6 × 103 mol-
ecules), as well as 1 pg mRNA (2.6 × 106 copies; highabun-
dance condition), in the presence of variable amounts of
background RNA. Using qPCR to measure the capacity of
the RT systems enabled us to determine two types of influ-
ence: the transcript abundance (low vs. high) and the
amount of background RNA (Figure 1). According to the
commercial RT systems and our own results, it is clear that
both parameters influence the DY (Table 2 and 3). A sig-
nificant difference was associated with the abundance of
the gene: greater differences between RT systems were
observed in low-abundance gene conditions. All quantita-
tive results obtained with undiluted RT samples presented
RT systems as being barely efficient for converting low-
copy transcripts, with the exception of SuperScript II.
Indeed, the SuperScript II system was more sensitive and
superior when compared with the other RT systems (Fig-
ure 1A). However, this particular aspect is not necessary
suitable in most qRT-PCR studies, since the objective is
usually directed towards the detection of differences in
transcript levels. In other words, "boosting" the low-abun-
dance genes might mask differences between samples.
In a paper reviewing the problems and limitations of qRT-
PCR, Bustin reported that Sensiscript and SuperScript II
deliver similar signals (Ct values) when detecting high-
abundance genes, whereas a fivefold increase was
observed with SuperScript II when a medium to low tran-
script amount was assayed [2]. These observations are in
keeping with our findings for lowabundance cDNA cop-
ies, although the efficiency of SuperScript II was about 10
times that of Sensiscript. For high-abundance mRNA con-
ditions, however, Sensiscript was superior to SuperScript
II. Indeed, when measuring an abundant transcript in the
presence of 1 to 2 µg background RNA, Sensiscript was
superior to the other tested systems for both the EGFP [see
Additional file 3] and GNPDA  [see Additional file 4]
genes. Furthermore, Sensiscript was slightly more sensi-
tive in the presence of less RNA and was superior to the
other tested systems at 50 ng background RNA (Figure 1B,
[see Additional file 3]). Therefore, in spite of the dynamic
range of this RT system (< 50 ng/µl; Table 1), the Sensis-
cript was highly efficient within the 25 to 2,000 ng range.
Influence of the background RNA
In their specifications, most of the commercial manufac-
turers indicate the dynamic range of their systems. How-
ever, the manufacturers do not present absolute
comparisons of the actual efficiency of their system in
terms of the RNA-to-cDNA conversion capacity of abun-
dant or rare transcripts in the presence of low background
RNA. In the present study, we measured the effects of non-
targeted background, i.e. total, RNA on the efficiency of
the qRT-PCR, as well as the impact on the PCR step. This
effect was measured using an exogenous transcript, EGFP,
and the endogenous GNPDA transcript, i.e. a biological
reference present in the background RNA. When detecting
the GNPDA transcript at 2 µg total RNA, Sensiscript was
two times better than the other three RT systems [see
Additional file 4], a finding that reflects a high-abundance
profile. The average number of GNPDA  mRNA copies
detected with Sensiscript was 42,488 ± 16% in 2 µg total
testis RNA (Table 2), which might represent around
430,000 copies in the whole RT sample (1/10 of the RT
reaction was used for qPCR assays). When comparing this
number to the EGFP low and high copy number condi-
tions (2.6 × 103 and 2.6 × 106molecules, respectively), we
may consider this GNPDA transcript to be mediumabun-
dance. In order to present an overall picture of these find-
ings, we summarised the three experiments, i.e. the low-
and high-abundance EGFP and the medium-abundance
GNPDA transcripts, in Figure 3 (same scales for EGFP and
GNPDA detection). The quantitative data for 1 pg EGFP
were therefore divided by 1,000 (based on the 1 fg assays),
and the GNPDA data were corrected for the amount of
background RNA in the assays. There is a clear trend
toward promoting the detection of high-abundance over
medium- and low-abundance transcripts in the presence
of low background RNA for all systems except for Super-
Script II, which was more efficient with lowabundance
transcripts (Figure 3A). Another interesting finding con-
cerns the efficiency of the Sensiscript system (Figure 3C).
Although the specificity of the RT was < 50 ng total RNA
(Table 1), this system was more efficient with 1 to 2 µgBMC Molecular Biology 2007, 8:93 http://www.biomedcentral.com/1471-2199/8/93
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total RNA for medium- and highabundance transcripts.
The third aspect that is worthy of note is the effect of back-
ground RNA on the endogenous GNPDA transcripts. Not-
withstanding SuperScript III and PowerScript (Figure 3B
and 3D), for which PCR-detected cDNA copies were too
low to be appreciated, more molecules were detected with
the Sensiscript system when the amount of total RNA
increased. This observation is in keeping with the RNA-
dependent RTase activity that was previously proposed
[8]. However, we observed a saturation effect above 1 to 2
µg background RNA that was more obvious with the
SuperScript II RT system and that could not be explained
by the dynamic range of the system. Indeed, we also tested
the RT systems by increasing the background RNA condi-
tion up to 5 µg total RNA. When RT reactions are not
diluted, there is no detection improvement from 1 µg up
to 5 µg for all RT systems (data not shown). There is there-
fore no benefit to using more than 1 µg total RNA when
undiluted RT reactions are used in qPCR assays.
It is still unclear how an increased amount of background
RNA (non-target RNA) introduced in RT reactions
increases the PCR sensitivity, a downstream application of
the RT step. In this study, we were able to observe a signif-
icant effect of the low background RNA when samples
were diluted. The dilution effect was partially released
when the amount of total RNA was higher (i.e. 1 to 2 µg;
Figure 2), but this inhibition release cannot be accounted
for by an increased amount of template, since the EGFP
transcript was not part of the background RNA but rather
Influence of the background RNA the on detection of EGFP and GNPDA cDNAs Figure 3
Influence of the background RNA the on detection of EGFP and GNPDA cDNAs. The high-abundance EGFP results 
were reported as 1 fg equivalent (i.e. divided by 1,000), whereas low-abundance EGFP results were uncorrected. Quantities of 
cDNA copies detected for GNPDA in total RNA (Table 2 and 3) were corrected for the amount of background RNA. Data for 
the SuperScript II, SuperScript III, Sensiscript, and PowerScript systems (panels A, B, C, and D, respectively) were plotted using 
the same scale for comparison purposes.
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a constant of the RT reaction. Indeed, variations in qRT-
PCR efficiency could not be accounted for by differences
in RT preparations either, since the same mix was distrib-
uted into reaction tubes containing variable amounts of
total RNA, for each RT system tested. Therefore, it became
obvious that the amount of background RNA alone
accounted for this discrepancy. Furthermore, the phe-
nomenon was only observable when using total RNA. As
reported else where [14], we did not observe any RT-PCR
performance improvement with tRNA (data not shown).
It has been suggested that RTase may exhibit several activ-
ities, including (i)RNAdependent DNA polymerase activ-
ity (RT activity) [15,16] (ii) DNA-dependent DNA
polymerase activity [17-19] (iii) terminal nucleotidyl
transferase-like activity (TdT) [20,21], (iv) strand transfer
and displacement ability [22,23], (v) positive effect on
PCR activity [6], (vi)DNA binding capacity [6], and (vii)
RNase H activity. Whereas both the Omniscript and Sen-
siscript RTases retain RNase H activity, the SuperScript II
and III systems have a mutated RTase with reduced RNase
H activity, and PowerScript lacks the RNase H enzyme
(Table 1). The results observed in this study may not be
attributable to the RNase H activity. Whereas some
authors observed that SuperScript III RTase (3.2 to 51.2 U
[units]) could have a positive effect on qPCR when intro-
duced in the PCR step [6], others reported the possible
loss of PCR sensitivity due to the interaction between the
RTase and DNA. One study concluded that this loss of
PCR sensitivity is mediated through a specific interaction
of the RTase with the primertemplate duplex rather than
with Taq polymerase itself [14]. Although it was demon-
strated that the introduction of nonhomologous RNA
relieves the amplification inhibition for the AMV H- RT
[24], no such effect was observable with the MMLV H- RT
[6,14]. However, the first statement resulted from an
experiment using yeast tRNA. It was reported that the
amount of total RNA does not affect the inhibitory proc-
esses, but this statement was made in regard to an experi-
ment where the proportion of the target gene versus total
RNA was maintained in the different SuperScript III RT
assays (i.e. by measuring an internal transcript using
either 50 ng or 1 µg RNA in the RT assay, the proportion
of target gene within the RNA pool is conserved) [6]. In
our TaqMan assays, the effect of the background RNA was
observed under a constant EGFP transcript level, and the
influence on the detection can only be mediated by non-
homologous RNA.
Since the amount of target transcripts was equally distrib-
uted throughout the RT reactions, and since the same RT
content was run as diluted or undiluted samples as
described above, an interaction of the background RNA in
the post-RT step, i.e. the PCR, was clearly indicated. It is
intriguing that the loss of PCR sensitivity was noticeable
when the target cDNA was favourably available for the
PCR reaction, i.e. in low background RNA conditions
where the proportion of the target transcript (EGPF) rela-
tive to total RNA was high. If the background RNA acted
simply as a chelator of PCR inhibitors, it is difficult to
explain why tRNA did not have an effect, unless this effect
is specific to mRNA. To add a degree of complexity to this
interpretation, the loss of PCR sensitivity was partially
released when RT samples were diluted. Therefore, we
cannot exclude that this variation (difference between
diluted and undiluted samples) originated from direct
competition between the Taq polymerase and the RTase.
Inhibition by the RT contents
The most striking aspect of our findings is the influence of
the RT contents on the subsequent PCR efficiency. This
observation was particularly evident for the Omniscript
system, where no detection was observed for the GNPDA
gene, whereas quantification of the EGFP gene was possi-
ble. Even though three sets of primers were designed and
tested, the presence of primer-dimers always masked any
relevant quantification. Since the observation was
restricted to the Omniscript system, i.e. since no such
primer-dimers were detected with the standard curve or
any of the other RT systems, it also suggests that the
Omniscript system would not be compatible with the
SYBR Green I chemistry, although we did not test another
testis gene. However, this observation does not rule out
the possibility that the presence of inhibitors could inter-
fere with the qRT-PCR reaction by generating the detected
primer-dimers. Indeed, we observed a great discrepancy
between the undiluted and diluted RT samples. The RT
systems produced very different DYs, ranging from no
detection with Omniscript to 102% efficiency with Super-
Script II in conditions of low-abundance transcripts,
which was reduced to 31% in highabundance conditions
(Table 2). Furthermore, this profile was greatly distorted
in a sidebyside comparison of the undiluted and diluted
samples (Figure 2). In some cases, such as with the
Omniscript system, a complete absence of PCR-detectable
cDNA copies with undiluted samples was observed when
more than 10,000 molecules could be detected in 50fold
diluted samples. It became evident that some RT systems
contain substantial amounts of PCR inhibitors. Conse-
quently, the next experiment was aimed at verifying the
extent of this influence on subsequent qPCR evaluations
by comparing serial dilutions of RT reactions. Previous
studies reported that, when a calibration curve for qPCR is
established with RT samples (i.e. serial dilutions), the
result is often a PCR efficiency greater than 100% [6,7].
The contribution of some RT components was evident
given the observed variations in the slope of the curve,
whether it included all dilutions or excluded the first
(undiluted sample) or first two dilution points (Table 4).
When the slope is inferior to -3.32, the PCR efficiency isBMC Molecular Biology 2007, 8:93 http://www.biomedcentral.com/1471-2199/8/93
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superior to 2(10(-1/slope)), meaning that each cycle gener-
ates more than twice the amount of cDNA copies, which
is impossible. This suggests the presence in the RT reaction
of PCR inhibitors, which are reduced in diluted samples.
All the RT systems tested in the present study, except Sen-
siscript, contain a substantial amount of inhibitors, given
the respective efficiencies that exceed 100%: 104.14 ±
2.42% for Omniscript, 123.79 ± 6.95% for SuperScript II,
161.44 ± 10.16% for SuperScript III, and 145.27 ± 5.49%
for PowerScript (Table 4). Using extreme points (undi-
luted and 128-fold diluted samples), we were able to cal-
culate the average IP. The most inhibitory RT system was
SuperScript III (79.31 ± 2.85%), whereas Sensiscript was
the least inhibitory with an IP of 14.73 ± 6.09%. Sensis-
cript was also the RT system that had the highest reliability
for amounts of background RNA between 0.1 and 2 µg
(Figure 2). While Omniscript was the least sensitive sys-
tem for both low and abundant target transcripts (Figure
1 and Table 2), it produced a weak IP of 31.23 ± 23.50%
(Table 1). However, we observed a major contribution of
the primer-dimer occurrence with the Omniscript system
when using the SYBR Green I chemistry. The lack of sensi-
tivity attributed to PCR inhibitors was noted before, but
the primer-dimer problem was not pointed out [25].
However, the enhanced production of artefacts, presuma-
bly primer-dimers, was reported elsewhere [26]. It was
also reported that a limited amount of template cDNA or
an increased cycle number beyond the linear PCR range
causes increased primer-dimer formation [13]. This was
not the case here, since this phenomenon was detected
with a medium level of GNPDA transcripts and in the
exponential phase of the reaction. Therefore, the problem
of primer-dimer occurrence with Omniscript is inherent
to this RT system. To ensure that the overall performance
of each RT system was not batch-dependent, we contacted
the respective companies. They did not report problems
with the batches used for the study. Clearly, all RT systems
have their respective attributes (primer-dimer formation
and PCR inhibition potential) and, obviously, different
RT systems are definitely not compatible within the same
qRT-PCR study. Furthermore, samples harbouring differ-
ent dilutions cannot be compared. Indeed, there is no
point in measuring differences between samples if these
differences are simply due to a differential concentration
of inhibitors or PCR boosters that belong to the RT step.
Generally, the experimental design of a qRT-PCR study is
established using equal amounts of RNA (total RNA or
mRNA). Furthermore, there is a clear trend toward using
relative quantification, i.e. to refer to a housekeeping or
stable gene, when variations in target gene expression are
examined. Indeed, the effect of the RT content (diluted or
not) on qPCR should not be affected by the presence of a
constant amount of background RNA. However, we can-
not exclude that a burst of RT of lowabundance transcripts
could have a significant effect on the profile.
Notwithstanding the accuracy of their experimental
designs, most of the qRTPCR studies do not consider the
deleterious effects of the RT buffer components. In the
best situations, RT cleanup using a silica-based column or
organic extraction, as suggested by Suslov and Steindler
[6], would be performed before RT samples are intro-
duced into the qPCR assay. These conditions are often
overlooked for practical reasons: the cleanup step is
expensive, organic extraction cannot be applied to large-
scale studies, and there is sometimes not enough RNA to
allow for the cleanup step–for the systems tested in the
present study, more than 50% of the RNA was lost when
the samples were passed through the column (data not
shown). Indeed, decreased sensitivity [2] and a one-log
reduction in the signal [27] when using a spin column for
RNA isolation have been reported. Consequently, it might
be wise to dilute the RT reactions in order to minimise the
inhibition effect [24] and relieve the Taq  polymerase/
RTase competition or interaction [6,14,26], as long as the
transcripts are still detectable following the dilution. A 10-
fold dilution is required to relieve the inhibition effect by
at least 50% [6,25], which would increase the Ct of sam-
ples by at least 3.3 units, keeping in mind that a ∆ Ct > 5
units is required to declare samples statistically different
from no-template controls [28].
Weak RTase efficiency and reproducibility, or the "Monte 
Carlo" effect
The RTase enzymes in the PowerScript, SuperScript II and
SuperScript III systems are engineered versions of the
enzyme derived from the Moloney murine leukaemia
virus (MMLV; manufacturers' manuals). The Omniscript
and Sensiscript RT enzymes are different from the MMLV
or avian myeloblastosis virus (AMV) RTases, and both
enzymes retain RNase H activity (Sensiscript and Omnis-
cript reverse transcriptase handbook, Qiagen). Previous
work reported that the Omniscript RTase is superior to
AMV or MMLV RTases [29]. However, we did not observe
such superiority in the Omniscript system under the same
conditions (1 to 2 µg RNA). Furthermore, whereas the
Omniscript and Sensiscript RTases are the same enzyme,
their respective systems do not have similar performances.
The nature of the RT enzyme cannot account for the
observed discrepancies.
The reproducibility of the RT assays is generally high, as
shown by the low SDs of the RT systems tested. However,
we observed an inherent limitation in PCR amplification
from small amounts of transcripts (1 fg EGFP). This obser-
vation has been related to the "Monte Carlo" phenome-
non [30], which is created by small and random
differences in amplification efficiency between individual
templates in a population where every template has a dif-
ferent probability of being processed. In other terms,
below a certain molar threshold, a specific transcriptBMC Molecular Biology 2007, 8:93 http://www.biomedcentral.com/1471-2199/8/93
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present in a complex mixture cannot be reproducibly
detected [30] and quantified [3,28] Karrer et al. [30]
asserted that rare mRNAs (< 0.04% of polyadenylated
mRNA) exhibited significant variations in gene detection
caused by the "Monte Carlo" effect and that an evaluation
would not be quantitative but rather qualitative under
these conditions. In our design, 1 fg EGFP mRNA repre-
sented about 0.00025% of mRNA content in the 10-ng RT
sample (taking into account that total RNA contains 3 to
5% mRNA), and 100 to 200 times less in the presence of
more background (1 to 2 µg). Therefore, the quantity used
could have been subjected to the "Monte Carlo" effect.
However, there are several pieces of evidence against this
effect. The difference between high and low gene abun-
dance was exacerbated in conditions of low background
RNA, a condition where the EGFP transcripts were propor-
tionally more abundant. Furthermore, both RT and PCR
amplification of EGFP and GNPDA transcripts, although
very low with the PowerScript and SuperScript III systems,
were still reproducible and consistent. The PCR step was
not influenced by the "Monte Carlo" effect, as demon-
strated in the experiment using diluted RT samples: the
absence of amplification of cDNAs was partially relieved
by dilution. The decreased performance could therefore
not be attributed to a weak probability of the cDNA mol-
ecule being amplified ("Monte Carlo" effect) but rather to
PCR inhibition. Consequently, it appears that the major
influencing component is the PCR inhibitors' content
itself.
More robust and qPCR-transposable RT systems are 
required
Great divergences in efficiency were observed among the
commercial RT systems tested in this study, and important
IP contributions to qPCR were detected. Both the back-
ground RNA and the RT contents are undeniably influenc-
ing factors. Therefore, these aspects should be considered
with caution. Companies should provide more detailed
information on their products, and an RT buffer with
information about its impact on PCR should be included
in order for reliable qRT-PCR studies to be performed.
Although the influence of RT on quantitative studies has
been underlined in published reviews [3,28], no studies
have quantified the efficiency of detection of low-abun-
dance transcripts in conditions of low background RNA.
This might be a critical step when only small amounts of
RNA are available and even more valuable when low-
abundance transcripts should not be missed. Indeed, low-
abundance transcripts are often important biological reg-
ulators (e.g. enhancers, silencers, transcription factors)
and therefore should not be overlooked in a gene expres-
sion analysis. In such conditions, choosing an RT system
such as SuperScript II that allows the detection of low-
abundance transcripts would be adequate for global tran-
script profiling. In contrast, when qRT-PCR studies are
performed in order to identify subtle differences, a repre-
sentative profiling of the transcript abundance is expected.
Indeed, a situation in which a gene present in low abun-
dance in some samples is overestimated in comparison to
samples where the transcript is present at higher levels is
not suitable. It appears from our study that the RT inhibi-
tor content largely influences the outcome profile of the
PCR-detectable molecules. Therefore, this crucial step
should be carefully set up when designing gene expression
studies.
Conclusion
While skills and experience are important for obtaining
reliable results in qRT-PCR studies, identifying the source
of variability is of prime importance. Indeed, there is no
point in using an onerous and highly accurate molecular
assay if the major sources of variability are underesti-
mated. We observed that detection limits vary extensively
among several commercial RT systems. When small differ-
ences among the RT systems (for a specific condition of
total RNA amount) were measurable in the detection of
an abundant transcript, the SuperScript II system was
more efficient in conditions of low transcript abundance.
However, it appears that the capacity for detecting low-
abundance cDNA not only is attributable to the efficiency
of the RT enzyme but is largely affected by some compo-
nents in the RT system that bias the subsequent PCR
amplification. Indeed, we quantified spurious differences
among the RT systems when undiluted cDNA templates
were used versus diluted samples. Therefore, a mandatory
purification or dilution step (at least 10-fold) of cDNA
templates will allow more accurate and sensitive measure-
ments. In practice, any manufacturer's claims need to be
treated cautiously. RT is an important step in a gene
expression study and should be considered with infinite
cautions when an absolute quantification is required.
Methods
Background RNA
Total RNA was extracted from 300 mg bovine testis tissue
kept in RNA later (Ambion). Extraction followed a stand-
ard Trizol®  Reagent (Invitrogen) protocol. RNA was
treated with bovine rDNase I (Ambion) and precipitated
in isopropanol. The pellet was dissolved in nucleasefree
water (Ambion) containing 1U/µl SUPERase•In™
(Ambion). The absence of genomic DNA was confirmed
with a PCR design spanning an intron and using the
bovine protamine 1 gene (PRM1; accession No.
NW_930382) and the human deleted-in-azoospermia-
like gene (DAZL; accession No. NM 001351), which are
testis-specific gene sequences. RNA quantification was
performed using a UV spectrophotometer (Ultrospec
3000, Pharmacia Biotech). The isolated RNA had an A260/
A280 ratio of 2. Serial dilutions of testis RNA (1,000 ng/µl,BMC Molecular Biology 2007, 8:93 http://www.biomedcentral.com/1471-2199/8/93
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500 ng/µl, 50 ng/µl, 25 ng/µl, 12.5 ng/µl, and 5 ng/µl)
were made in nuclease-free water containing 1 U/µl
SUPERaseIn to perform the RT reactions.
DNA standard curves
Reference genes, i.e. the enhanced green fluorescent gene
(EGFP; accession no. U55762) and the oscillin gene
(GNPDA; accession no. XM_881844), were amplified
using primers specific to the desired application (standard
curve, qRT-PCR, in vitro transcription, or end-point; [see
Additional file 1]). Primers were designed using PrimerEx-
press 2.0 software (Applied Biosystems). Standard curves
for the EGFP and GNPDA genes were constructed with a
PCR product, using pEGFP-N1 plasmid (Clontech) or
bovine testis cDNA, respectively, as template. PCR reac-
tion was performed as follows: initial denaturation at
94°C for 2 min, followed by 35 cycles consisting of dena-
turation at 94°C for 30 s, annealing at 65°C for 30 s, and
extension at 72°C for 45 seconds, with a final extension
step at 72°C for 2 min. The single-band amplicons were
visualised on a 1.5% agarose gel stained with ethidium
bromide, purified using the QIAquick PCR Purification
Kit (Qiagen), and verified by sequencing. For that pur-
pose, the amplicons were cloned into the T/A plasmid vec-
tor pCRII (Invitrogen) according to the manufacturer's
instructions. In order to confirm amplicon identities,
sequencing reactions were performed using BigDye Ter-
minator (version 3.1; Applied Biosystems) chemistry and
a 9700 thermal cycler (Applied Biosystems). The PCR pro-
gram for all sequencing reactions included initial denatur-
ation at 96°C for 1 min, followed by 25 cycles consisting
of denaturation at 96°C for 10 s, primer annealing at
50°C for 5 s, and extension at 60°C for 4 min. The
sequencing products were purified by ethanol/EDTA pre-
cipitation, resuspended in a formamide solution (Applied
Biosystems), and analysed with the ABI 3100-Avant capil-
lary sequencer (Applied Biosystems). Gene homology was
confirmed via the BLAST network service of the National
Center for Biotechnology Information (NCBI) [31]. For
each reference gene, the products of the PCR reactions
were cleaned using a PCR purification kit (Qiagen). Dilu-
tions of purified amplicons for qRT-PCR were made in
nucleasefree water (Ambion).
EGFP mRNA synthesis by in vitro transcription
Chimera primers containing a T7 promoter and a polyT
tail [see Additional file 1] were used in a touchdown PCR
in a GeneAmp 9700 (Applied Biosystems). PCR reaction
was performed as follows: initial denaturation at 94°C for
3 min, followed by 10 cycles consisting of denaturation at
94°C for 30 s, annealing at 65°C for 30 s, and extension
at 72°C for 45 s, with a reduction of the annealing tem-
perature by 0.5°C during each cycle. PCR reaction was
continued for an additional 33 cycles with annealing at
59°C for 30 s. PCR reaction was cleaned with the
QIAquick PCR Purification Kit (Qiagen). T7 in vitro tran-
scription using 275 ng EGFP PCR product was used to
produce the spiking RNA to monitor RT with AmpliScribe
T7, T3, and SP6 High Yield Transcription Kits (Epicentre).
T7 transcription reaction was carried out for 2 h at 37°C,
and the product was treated with DNase I. RNA was iso-
lated with phenol/chloroform/isoamyl alcohol and pre-
cipitated with 7.5 M ammonium acetate, ethanol and
linear acrylamide (Ambion). The pellet was washed and
dissolved in nuclease-free water with 1U/µl SUPERaseIn,
and the quantity of RNA was estimated with a 1:2,000
dilution of RiboGreen reagent (Molecular Probe).
Reverse transcription
RNA samples used as background material for the RT
assays were prepared (serial dilution from the same RNA
pool; see above) in aliquots of 10, 25, 50,100, 1,000, and
2,000 ng total testis RNA. The aliquots were used once to
avoid a freeze-and-thaw influence on the cDNA quality.
All the RT reactions were prepared using one master mix
for the respective enzyme, spiked with 1 fg or 1 pg EGFP
mRNA template, and then distributed in the background
RNA aliquots. Each RT assay was performed in a 20-µl
reaction using oligo(dT)12–18 (Invitrogen) as primer and
following the recommendations of the supplier. Unless
otherwise stated, all the RT reactions were performed in
triplicate, for each dilution point and each RT system, in a
PTC-200 thermal cycler (MJ Research). All the RT systems
screened in this study, i.e. Sensiscript and Omniscript
(Qiagen), SuperScript™ II and SuperScript™ III (Invitro-
gen), and PowerScript™ (Clontech, Mountain View, CA),
were used strictly in accordance with the recommenda-
tions of the respective suppliers.
Detection of cDNA synthesis in RT reactions by real-time 
PCR
Quantitative RT-PCR was performed in triplicate in a
7700 SDS thermal cycler (Applied Biosystems). For quan-
tification of EGFP, the hydrolysis probe technology (i.e.
TaqMan probes [32]; [see Additional file 1]) was used as
the detection system. The PCR mixture contained 12.5 µl
2X TaqMan Universal Master Mix (Applied Biosystems),
0.3 µM forward and reverse primers, 0.2 µM probe, and 2
µl cDNA (diluted or not). To reach the final volume of 25
µlper well, nuclease-free water was added. For quantifica-
tion of GNPDA, the SYBR Green chemistry was used. Both
the EGFP and the GNPDA genes were quantified using
aliquots prepared from the same RT samples, avoiding
variations attributed to the difference between RT assays.
The absence of primer-dimers for both the EGFP and the
GNPDA genes was validated using the SYBR Green I tech-
nique [33]. PCR reactions contained 12.5 µl 2X Power
SYBR Green Master Mix (Applied Biosystems), 0.3 µM for-
ward and reverse primers, and 0.25 U AmpErase UNG
(Applied Biosystems). All runs (i.e. plates) included a trip-BMC Molecular Biology 2007, 8:93 http://www.biomedcentral.com/1471-2199/8/93
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licate of the standard curve and threeto six negative con-
trols without target DNA that were partitioned at the
beginning and the end of the plate. Thermal cycling con-
ditions were as follows: 50°C for 2 min (incubation for
the AmpErase UNG) preceding the first denaturation step
at 95°C for 10 min, followed by 40 cycles of 95°C for 15
s and 60°C for 1 min. Melting curves analysis was per-
formed for SYBR Green amplifications by plotting the flu-
orescence intensity in a graphic model. The presence of a
single melting temperature peak (SYBR Green amplifica-
tions), which represented a specific amplicon, and that of
the products of the TaqMan assays were confirmed by a
run on a 2.5% agarose gel stained by SYBR gold nucleic
acid stain (Invitrogen).
Data analysis
Quantitative RT-PCR data were analysed using the appro-
priate threshold set up as recommended by Applied Bio-
systems [34] before being transferred to Excel. The slope
of the calibration curve was calculated from the plot of
base 10 log of initial target copy number versus corre-
sponding Ct. The PCR efficiency (E) was determined from
the slope of the curve obtained with serially diluted sam-
ples, as E = 10(-1/slope), whereas the number of gene copies
in each RT sample was calculated from the calibration
curve. Basic statistical analyses were performed using
Excel, and ANOVA was performed using SAS (Statistical
Analysis System, Release 9.1, 2002, SAS Institute Inc.,
Cary, NC).
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